CHIP News and Research

RSS
U-M researchers devise reliable way to grow tumor cells

U-M researchers devise reliable way to grow tumor cells

UCLA researchers develop lens-free microscope that can detect cancer, other cell-level abnormalities

UCLA researchers develop lens-free microscope that can detect cancer, other cell-level abnormalities

Study points to need for improving pediatric benefits under the Affordable Care Act

Study points to need for improving pediatric benefits under the Affordable Care Act

Breakthrough research could lead to prosthetic retinas for people suffering from retinal damage

Breakthrough research could lead to prosthetic retinas for people suffering from retinal damage

Fiagon's ENT Extended Instrument Set receives FDA approval

Fiagon's ENT Extended Instrument Set receives FDA approval

Real-time surgical guidance study to evaluate TriVersa NanoMate with LESA capability from Advion

Real-time surgical guidance study to evaluate TriVersa NanoMate with LESA capability from Advion

Choosing the best way to verify the quality and quantity of Chromatin Immunoprecipitation DNA

Choosing the best way to verify the quality and quantity of Chromatin Immunoprecipitation DNA

IBM, ASU scientists develop prototype DNA reader

IBM, ASU scientists develop prototype DNA reader

Three Johns Hopkins hospitals recognized as Top Performer on Key Quality Measures

Three Johns Hopkins hospitals recognized as Top Performer on Key Quality Measures

Cookie Monster video helps preschoolers develop skills critical to school readiness

Cookie Monster video helps preschoolers develop skills critical to school readiness

D-LIVER project aims to help patients with chronic liver disease

D-LIVER project aims to help patients with chronic liver disease

EKF Molecular Diagnostics to present at AMP annual meeting

EKF Molecular Diagnostics to present at AMP annual meeting

Johns Hopkins engineers invent lab device that yields microscopic look at metastasis

Johns Hopkins engineers invent lab device that yields microscopic look at metastasis

Myriad's Prolaris test included in NCCN Guidelines for men with localized prostate cancer

Myriad's Prolaris test included in NCCN Guidelines for men with localized prostate cancer

Viewpoints: Fund CHIP; media overdrive on Ebola; slowdown in Medicare costs

Viewpoints: Fund CHIP; media overdrive on Ebola; slowdown in Medicare costs

Next generation sequencing applications automated through partnership between Beckman Coulter Life Sciences and New England Biolabs

Next generation sequencing applications automated through partnership between Beckman Coulter Life Sciences and New England Biolabs

Viewpoints: Health law fails to control costs; GOP alternative 'worse than Obamacare'

Viewpoints: Health law fails to control costs; GOP alternative 'worse than Obamacare'

HealthCare Royalty Partners closes $1.5B for HealthCare Royalty Partners III, L.P., affiliated entities

HealthCare Royalty Partners closes $1.5B for HealthCare Royalty Partners III, L.P., affiliated entities

State highlights: Calif.'s Prop. 45 fight; new benefits for same sex couples in N.C.; Aetna sheds jobs after Medicaid drop

State highlights: Calif.'s Prop. 45 fight; new benefits for same sex couples in N.C.; Aetna sheds jobs after Medicaid drop

Viewpoints: Abortion and birth control issues in N.C. Senate race; replacing Obamacare; cancellations

Viewpoints: Abortion and birth control issues in N.C. Senate race; replacing Obamacare; cancellations

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.